1018297-63-6

Basic information

• Product Name: 3-(4-fluorophenyl)-5-Methyl-4-IsoxazoleMethanol
• Synonyms: 3-(4-fluorophenyl)-5-Methyl-4-IsoxazoleMethanol;[3-(4-Fluorophenyl)-5-methylisoxazol-4-yl]methanol
• CAS NO: 1018297-63-6
• Molecular Formula: C₁₁H₁₀FNO₂
• Molecular Weight: 207.2010032
• Mol File: 1018297-63-6.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 378.549 °C at 760 mmHg
• Flash Point: 182.74 °C
• Appearance: /
• Density: 1.255 g/cm³
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-(4-fluorophenyl)-5-Methyl-4-IsoxazoleMethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-fluorophenyl)-5-Methyl-4-IsoxazoleMethanol(1018297-63-6)
• EPA Substance Registry System: 3-(4-fluorophenyl)-5-Methyl-4-IsoxazoleMethanol(1018297-63-6)

Safety Data

• Hazardous Substances Data: 1018297-63-6(Hazardous Substances Data)

Usage

General Description

3-(4-fluorophenyl)-5-Methyl-4-IsoxazoleMethanol, also known as 4-Fluorophenyl isoxazole-5-methanol, is a synthetic compound with potential antifungal and antiparasitic properties. It is an isoxazole derivative that has been studied for its potential use in treating infectious diseases. This chemical is a white to off-white crystalline powder that is soluble in organic solvents and has a molecular formula of C10H9FNO2. It has been the subject of research for its potential therapeutic applications, particularly in the field of infectious diseases, and may have the potential to be developed into new pharmaceutical drugs.

Upstream product

• 42202-95-9 4-fluoro-N-hydroxybenzimidoyl chloride 
• 393165-20-3 (Z)-N-hydroxy-4-fluoro-benzenecarboximidoyl chloride 
• 1736-21-6 3-(4-fluoro-phenyl)-5-methyl-isoxazole-4-carboxylic acid 
• 459-23-4 4-fluorobenzaldoxime 
• 459-57-4 4-fluorobenzaldehyde 
• 954230-39-8 3-(4-fluoro-phenyl)-5-methyl-isoxazole-4-carboxylic acid ethyl ester 

Downstream Products

• 1159600-43-7 5-bromo-2-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-pyridine 
• 1159251-74-7 2-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethyl]-isoindole-1,3-dione 
• 1159600-38-0 6-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-N-(tetrahydro-pyran-4-yl)-nicotinamide 
• 1159600-41-5 (1,1-dioxo-1λ⁶-thiomorpholin-4-yl)-{6-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-pyridin-3-yl}-methanone 
• 1159600-36-8 6-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-N-isopropyl-nicotinamide 
• 1159600-35-7 N-cyclopropylmethyl-6-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-nicotinamide 
• 1159600-39-1 {6-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-pyridin-3-yl}-morpholin-4-yl-methanone 
• 1159600-34-6 6-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-N-(2,2,2-trifluoro-ethyl)-nicotinamide 
• 1159600-32-4 6-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-nicotinic acid 
• 1431329-33-7 6-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-nicotinonitrile 
• 1159600-30-2 6-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-nicotinic acid methyl ester 
• 1240402-76-9 3-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-isoxazole-5-carboxylic acid methyl ester 
• 1159251-88-3 6-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-[1,2,4]triazolo[4,3-b]pyridazine 

Relevant articles and documents

(1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV

The invention relates to an administration unit comprising a compound of formula and/or pharmaceutically acceptable salts thereof, and to a packaging comprising the administration unit according to the invention.

NOVEL SOLID FORMS

The instant invention relates to novel solid forms of the compound of formula (I) as well as solvates, inclusion complexes with other suitable compounds, processes for their manufacture, pharmaceutical compositions containing these solid forms, and their

PROCESS FOR THE PREPARATION OF ISOXAZOLYL-METHOXY-NICOTINIC ACIDS

The present invention relates to a process for the preparation of a compound of formula (I) which is useful as an intermediate in the preparation of active pharmaceutical compounds from a compound of formula (IV) wherein R1 and R2 ar